ethylene oxide has been researched along with Glioblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
1 other study(ies) available for ethylene oxide and Glioblastoma
| Article | Year |
|---|---|
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coumarins; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Ethylene Oxide; Glioblastoma; Kaplan-Meier Estimate; Lactones; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; Paclitaxel; Protamines; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution | 2013 |